Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Link
http://www.nature.com/articles/modpathol201574.pdf
Reference81 articles.
1. Esserman LJ, Woodcock J . Accelerating identification and regulatory approval of investigational cancer drugs. JAMA 2011;306:2608–2609.
2. Cortazar P, Zhang L, Untch M et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 2014;384:164–172.
3. Mamounas EP, Anderson SJ, Dignam JJ et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol 2012;30:3960–3966.
4. Apple SK, Suthar F . How do we measure a residual tumor size in histopathology (the gold standard) after neoadjuvant chemotherapy? Breast 2006;15:370–376.
5. Kuroi K, Toi M, Tsuda H et al. Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Breast Cancer 2006;13:38–48.
Cited by 209 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pathological response and tumor stroma immunogenic features predict long-term survival in non-small cell lung cancer after neoadjuvant chemotherapy;Cellular Oncology;2024-02-06
2. Assessment of residual cancer burden and survival in neoadjuvant chemotherapy of inoperable stage III breast cancer: A ten-year follow-up analysis in Vietnam;Pathology - Research and Practice;2024-02
3. Changing the phenotype of breast cancer in the process treatment: literature review;Surgery and Oncology;2024-01-04
4. Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy;Modern Pathology;2024-01
5. Pathologic Evaluation and Reporting of Breast and Axillary Lymph Node Specimens;Tumors of the Mammary Gland;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3